Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $71.19 ($649K) on 2015-08-03, disclosed to the SEC on 2015-08-04.
Scheduled sale ($649k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.19 | 3,669 | $261K | 40.2% |
| 2 | $72.33 | 2,784 | $201K | 31.0% |
| 3 | $73.03 | 1,857 | $136K | 20.9% |
| 4 | $74.01 | 690 | $51K | 7.9% |
| Total | $72.14 avg | 9,000 | $649K | 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |